Download | < Back |
10 Apr 2017 | |
Pursuant to the provisions of Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the details of investor grievances for the quarter ended 31st March, 2017. No. of investor complaints pending at the beginning of quarter NIL No. of investor complaints received during the quarter NIL No. of investor complaints disposed off during the quarter NIL No. of investor complaints those remaining unresolved at the end of the quarter NIL | |
View all announcements for POLY MEDICURE LTD. | Source: BSE India |